Scribe Therapeutics, Inc.(SCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SCTX Scribe Therapeutics, Inc.

交易中 10-22 15:43:00 EDT

17.88

-1.42

-7.36%

最高19.11	最低16.40	成交量58.04万
今开19.00	昨收19.30	日振幅14.04%
总市值3.38亿	流通市值1.23亿	总股本1,893万
成交额1,022万	换手率8.43%	流通股本688.91万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SCTX","market":"US","secType":"STK","nameCN":"Scribe Therapeutics, Inc.","latestPrice":17.88,"timestamp":1792698180152,"preClose":19.3,"halted":0,"volume":580408,"delay":0,"changeRate":-0.07357512953367884,"floatShares":6889056,"shares":18931680,"eps":-13.17626,"marketStatus":"交易中","change":-1.42,"latestTime":"10-22 15:43:00 EDT","open":19,"high":19.11,"low":16.4001,"amount":10219599.446104001,"amplitude":0.140409,"askPrice":18.11,"askSize":100,"bidPrice":17.83,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-13.17626,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"listingDate":1784865600000,"exchange":"NASDAQ","adjPreClose":19.3,"preHourTrading":{"tag":"盘前","latestPrice":19.22,"preClose":19.3,"latestTime":"09:29 EDT","volume":670,"amount":12865.38958,"timestamp":1792675799999,"change":-0.08,"changeRate":-0.004145,"amplitude":0.045078},"postHourTrading":{"tag":"盘后","latestPrice":19.76,"preClose":19.3,"latestTime":"19:30 EDT","volume":4453,"amount":86601.59,"timestamp":1792625400108,"change":0.46,"changeRate":0.023834,"amplitude":0.024352},"volumeRatio":2.273638},"requestUrl":"/m/hq/s/SCTX","defaultTab":"news","newsList":[{"id":"1167802163","title":"“木头姐”逆势抄底奈飞，连续三日减持Palantir近千万美元！多家华尔街大行下调奈飞目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1167802163","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167802163?lang=zh_cn&edition=full","pubTime":"2026-10-22 14:10","pubTimestamp":1792649408,"startTime":"0","endTime":"0","summary":"业绩公布后，多家华尔街机构下调奈飞目标价。连续三日减持Palantir，累计套现约960万美元在买入奈飞的同时，方舟投资继续减持人工智能软件公司Palantir。这已是方舟投资连续第三个交易日减持Palantir。尽管Palantir业务保持高速增长，但其高估值已引发市场关注。不过，Palantir国际商业业务的采用速度仍落后于美国本土市场。从最新交易来看，方舟投资在奈飞股价回落后选择增持，同时连续减持估值较高的Palantir，并继续布局核能、基因科技及航天等创新领域。","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKLC","ARKW","AMAA","LUNR","AMZD","AMZP","AMZY","NFX","SHPU","AMZG","OKLS","NFLX","AMZW","AMZO","SHOP","AMZN","SHPD","XE","NFLU","AMZZ","ESLT","LUNL","OKLL","ARKK","NFXL","NFXS","OKLO","NFLW","NFLY","SCTX","NFLP","AMZU","AZYY","PSNL","ISRG","ISUL","PACB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1105379422","title":"Scribe Therapeutics 2026年第二季度净亏损650万美元，每股亏损2.62美元，较2025年同期亏损显著收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1105379422","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105379422?lang=zh_cn&edition=full","pubTime":"2026-09-03 04:15","pubTimestamp":1788380109,"startTime":"0","endTime":"0","summary":"Scribe Therapeutics, Inc. 最新财务报告显示，该公司在2026年第二季度录得净亏损650万美元，折合每股亏损2.62美元。相较于2025年同期990万美元的净亏损及每股4.08美元的亏损水平，本季度亏损幅度明显收窄，财务状况呈现改善趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010113","title":"错峰抄底重仓特斯拉 木头姐ARK Invest完成全品类持仓调仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010113","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654010113?lang=zh_cn&edition=full","pubTime":"2026-07-27 20:12","pubTimestamp":1785154356,"startTime":"0","endTime":"0","summary":"金吾财讯｜凯茜·伍德旗下ARK Invest完成大规模双向调仓操作，整体延续聚焦AI、自动驾驶、太空科技、创新医疗、金融科技的核心投资主线，在多赛道加码优质标的，同时对部分科技、工业、医疗标的获利减持，持仓结构进一步优化。本期最大手笔增持为特斯拉，在特斯拉二季度财报不及预期、单日暴跌约15%创下一年最大单日跌幅后，ARK Invest逆势加仓价值5270万美元的特斯拉股票。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303054","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST","CDNA","AMDL","ARKG","LLY","HOOD","SMH","SHOP","ILMN","ARKK","CRCL","SNOW","TEM","ESLT","LTL","MAGY","SRTA","ABSI","SHPD","BULZ","IRDM","ATAI","NTRA","TSLA","ARKF","SCTX","TXG","SARK","OGIG","TSLL","PRME","IXJ","YMAG","AMD","ARKW","CMPS","CAT","ARKB","XE","META","ARKQ","ARKX","BIDU","ACHR","VEGI","ROKU","TER","DE","FIG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2654041058","title":"礼来支持的Scribe Therapeutics美国IPO，首日飙升超44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654041058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654041058?lang=zh_cn&edition=full","pubTime":"2026-07-25 08:39","pubTimestamp":1784939999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2357305700.SGD","LU1804176565.USD","LU1989771016.USD","FTXH","BK4581","LU0210536198.USD","LU2471134796.USD","OZEM","LU2746668461.USD","LU0786609619.USD","CANC","LU2361044865.SGD","SG9999018857.SGD","LU0820562030.AUD","LU0203201768.USD","SG9999014880.SGD","IE00B775H168.HKD","MEDI","LU0256863811.USD","LU2023250504.SGD","LLYX","MHIP","LU0158827781.USD","LU2089283258.USD","LU0471298777.SGD","LU0323591593.USD","LU0456855351.SGD","LU0672654240.SGD","LU0289739699.SGD","LU2063271972.USD","LU2089984988.USD","LU2462157665.USD","LU2746668974.SGD","BK4533","ELIL","SCTX","SG9999014906.USD","SG9999014914.USD","IE0002141913.USD","LU0708995401.HKD","LU1127390331.HKD","LU2237443895.HKD","LU2471134523.USD","LU1983299246.USD","LU1267930730.SGD","LU0234572021.USD","LU1069344957.HKD","LU2111349929.HKD","IE00B7KXQ091.USD","SGXZ99366536.SGD","TMED","LU1291159041.SGD","LU1280957306.USD","LU0354030438.USD","LU1323610961.USD","LU1629891620.HKD","HRTS","IE00B1BXHZ80.USD","IYH","XLV","AGNG","LU0174119429.USD","LU0882574055.USD","SGXZ51526630.SGD","IE00BKPKM429.USD","LU0109391861.USD","LU0114720955.EUR","LU1366192091.USD","LU0122379950.USD","LU1974910355.USD","IE00BWXC8680.SGD","IE0009355771.USD","SG9999001176.SGD","LU1551013342.USD","LU2237443622.USD","LLY","LU0238689110.USD","LU2417539215.USD","LU2491050154.USD","LU0320765059.SGD","LU2108987350.USD","LU0097036916.USD","LU1720051017.SGD","LU2237438978.USD","LU0471298694.HKD","LU0109394709.USD","LU2023251221.USD","LU1057294990.SGD","MEDX","LU0882574139.USD","LU2264538146.SGD","LU1061106388.HKD","SGXZ81514606.USD","IE00BJLML261.HKD","IXJ","LU1093756168.USD","IE00BK4W5L77.USD","LU2168564222.USD","LU0094547139.USD","LU2168563687.JPY","GB00BDT5M118.USD","PJP","LU1868837136.USD","LU0006306889.USD","LU0096364046.USD","SG9999015945.SGD","SGXZ31699556.SGD","LU2087625088.SGD","BK4516","LU0417517546.SGD","LU2237443382.USD","SG9999017495.SGD","BK4585","LU0256863902.USD","IE00BFSS8Q28.SGD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU0345770308.USD","LU0353189680.USD","LU2028103732.USD","LU2324357040.USD","LU0823416689.USD","IE00B1XK9C88.USD","LU2896262040.SGD","LU2237443549.SGD","LU2471134879.HKD","LU1988902786.USD","LU0466842654.USD","IHE","LU0820561818.USD","IE00B4JS1V06.HKD","GDOC","LU1548497426.USD","WDNA","LU2106854487.HKD","LU2360106947.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2236285917.USD","LU0353189763.USD","LU2361045086.USD","LU1093756325.SGD","IE0004445239.USD","LU0787776722.HKD","LU2237443978.SGD","SG9999015986.USD","LU2461242641.AUD","LU1035775433.USD","LU2552382215.SGD","BK4588","LU0354030511.USD","LU0058720904.USD","LU0225283273.USD","SG9999013999.USD","LU0203202063.USD","LU2168564065.EUR","LU2602419157.SGD","IE00BN29S564.USD","LU1712237335.SGD","LU0689472784.USD","LU0320765992.SGD","LU0106261372.USD","IE00BFTCPJ56.SGD","LU2552382058.USD","LU0964807845.USD","LU1868836914.USD","LU2168564149.EUR","LU0345770993.USD","LU0823434583.USD","FHLC","SG9999018865.SGD","ILDR","LU0943347566.SGD","IE00BJJMRX11.SGD","LU0385154629.USD","LU2265009873.SGD","LU1868837300.USD","IE0001KFT4U8.USD","LU2491049909.HKD","IE00B4R5TH58.HKD","LU2552382132.HKD","SG9999015978.USD","THNR","IE00BKDWB100.SGD","LU1023059063.AUD","LU1868836757.USD","TRUH","LU2023250330.USD","LU2168564495.EUR","LU1814569148.SGD","LU2271345857.HKD","LU1623119135.USD","BK4534","LU0079474960.USD","SG9999001176.USD","SG9999014898.SGD","LU1917777945.USD","LU1232071149.USD","LU2462591350.SGD","LU2112291526.USD","SGXZ57979304.SGD","LU2468319806.SGD","LLYZ","BK4007","LU0198837287.USD","LU0823434740.USD","LU1551013425.SGD","LU0061475181.USD","LU2491050071.SGD","IE0004445015.USD","LLII","LU2756315664.SGD","LU1145028129.USD","LU2750360641.GBP","IE00BJJMRY28.SGD","CURE","LU0266013472.USD","LU2213496289.HKD","LU0316494557.USD","LU1064131342.USD","PPH","SG9999015952.SGD","LU0432979614.USD","LU1720051108.HKD","RXL","BK4599","LU2089284900.SGD","IE0005OL40V9.USD","LU2750360997.AUD","ELIS","LU2756315318.SGD","LU1868836591.USD","LU0133085943.USD","LU2211815571.USD","JDOC","LU2471134952.CNY","VHT","LU0640476718.USD","LU2456880835.USD","LU0158827948.USD","IE00BK4W5M84.HKD","LU0820561909.HKD","LU2361044949.HKD","LU0683600562.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036699","title":"美股异动 | CRISPR基因编辑公司Scribe Therapeutics(SCTX.US)登陆美股市场 开盘后涨超59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654036699?lang=zh_cn&edition=full","pubTime":"2026-07-24 23:57","pubTimestamp":1784908651,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SCTX","ARKG","SYNB","GNOM","CRSP","BK4611","HELX","LU1861559042.SGD","NBDS","FWD","BK4539","BK4585","LENZ","DTEC","LU1861558580.USD","BK4139","BK4556","BK4007","BMED","IDNA","TARK","WDNA","KOMP","XT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653870111","title":"礼来、赛诺菲双重背书！Scribe Therapeutics(SCTX.US)扩大IPO规模：顶格募资约1.29亿美元，周五登陆美股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653870111","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653870111?lang=zh_cn&edition=full","pubTime":"2026-07-24 14:56","pubTimestamp":1784876216,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，当AI概念股在IPO市场遭遇寒流之际，由诺贝尔化学奖得主Jennifer Doudna联合创立的CRISPR基因编辑公司Scribe Therapeutics Inc.却在纳斯达克掀起了一波逆势热潮。IPO细节：扩大发行、定价高端、赛诺菲同步入股Scribe Therapeutics最初于7月21日公布IPO条款，计划以每股13至15美元的价格发行720万股，募资约1亿美元。赛诺菲与礼来均为Scribe的现有战略合作伙伴。赛诺菲则在IPO同步私募中投入750万美元购入股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"礼来、赛诺菲双重背书！Scribe Therapeutics(SCTX.US)扩大IPO规模：顶格募资约1.29亿美元，周五登陆美股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SCTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653224174","title":"心血管疾病生物科技公司Scribe(SCTX.US)IPO定价13-15美元/股 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653224174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653224174?lang=zh_cn&edition=full","pubTime":"2026-07-21 15:16","pubTimestamp":1784618217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","UUP","SYNB","IEIH","XBI","BK4581","BK4588","GDOC","MEDX","SCTX","AGNG","LNGR","UDN","BK4585","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scribetx.com","stockEarnings":[{"period":"1week","weight":-0.0708},{"period":"1month","weight":-0.3119},{"period":"3month","weight":0.2867},{"period":"ytd","weight":0.2867}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0005},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0829},{"period":"1year","weight":0.1516},{"period":"ytd","weight":0.1337}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scribe Therapeutics, Inc.于2017年6月30日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，致力于研发专用的体内CRISPR技术，旨在通过疾病预防和持久的治疗干预来延长健康寿命。公司正着力开发其技术，用于治疗影响数百万人的常见疾病，尤其关注那些存在巨大未满足需求和沉重临床负担的流行疾病。公司专注于心血管和代谢疾病，其初期项目旨在解决动脉粥样硬化性心血管疾病的关键驱动因素。公司正在设计基于CRISPR的基因药物，力求使其具有良好的耐受性、有效性、持久性和可扩展性，从而将治疗模式从症状驱动的干预和慢性病管理转变为人群层面的预防。公司的主要候选产品利用其高度工程化的表观遗传沉默技术，旨在实现持久有效的LDL-C降低，且不会造成永久性基因改变。","exchange":"NASDAQ","name":"Scribe Therapeutics, Inc.","nameEN":"Scribe Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scribe Therapeutics, Inc.(SCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Scribe Therapeutics, Inc.(SCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Scribe Therapeutics, Inc.,SCTX,Scribe Therapeutics, Inc.股票,Scribe Therapeutics, Inc.股票老虎,Scribe Therapeutics, Inc.股票老虎国际,Scribe Therapeutics, Inc.行情,Scribe Therapeutics, Inc.股票行情,Scribe Therapeutics, Inc.股价,Scribe Therapeutics, Inc.股市,Scribe Therapeutics, Inc.股票价格,Scribe Therapeutics, Inc.股票交易,Scribe Therapeutics, Inc.股票购买,Scribe Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scribe Therapeutics, Inc.(SCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Scribe Therapeutics, Inc.(SCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}